You’ve probably heard that extra-virgin olive oil is good for you.
But lately, a more specialized version has been getting attention:
High-polyphenol olive oil.
The pitch is intriguing.
Some olive trees grow under harsh conditions—intense sun, little water, rocky soil. The theory is that when plants are stressed, they produce more protective compounds.
And some olive oils made from those olives can contain unusually high concentrations of polyphenols.
Two prominent doctors have helped bring the idea into the spotlight.
Dr. Steven Gundry promotes a Moroccan desert-grown olive oil that he says contains up to 30 times more hydroxytyrosol polyphenols than conventional olive oils.
Dr. William Li, a physician and vascular scientist, partnered with Kosterina on a high-phenolic extra-virgin olive oil shot that the company says contains more than 1,000 mg/kg of polyphenols.
Both are making a fascinating argument:
Maybe not all extra-virgin olive oils are created equal.
But here’s the question worth asking:
Does consuming an exceptionally high-polyphenol olive oil actually make you healthier?
The answer isn’t as simple as the marketing.
First, what are polyphenols?
Polyphenols are naturally occurring compounds found in plants.
Olives contain several different polyphenols, including hydroxytyrosol and tyrosol.
Some have antioxidant and other biological effects, which is one reason researchers are interested in them.
And there really can be substantial differences in polyphenol content between olive oils.
So the basic idea isn’t nonsense.
The question is what happens when you deliberately seek out an oil with much more of these compounds.
Dr. Gundry’s desert olive oil
Dr. Steven Gundry has built a particularly strong story around Moroccan olive trees growing under harsh environmental conditions.
His materials describe the trees as growing in intense sun, dry air, limited rainfall and challenging soil. He argues that this environmental stress causes the trees to produce protective compounds—particularly polyphenols.
Gundry says the resulting oil contains up to 30 times more hydroxytyrosol polyphenols than conventional olive oils.
In one account published on his website, Gundry describes visiting the Moroccan grower and says testing showed polyphenol levels 30 times higher than French government assays had previously seen.
His current marketing goes further.
Gundry describes the oil as a concentrated way to obtain the benefits associated with much larger amounts of conventional olive oil and recommends roughly ½ tablespoon per day. His materials also promote the oil for a wide range of wellness benefits.
That’s a remarkable claim.
But there’s an important distinction:
Gundry’s 30× figure is a claim made by the product’s promoter.
It doesn’t automatically establish that the oil produces 30 times the health benefit.
And that’s where the science becomes important.
Dr. William Li takes a similar idea in a different direction
Dr. William Li has also become an advocate for high-phenolic olive oil.
Kosterina says its high-phenolic EVOO shot was developed in partnership with Li, who serves as the company’s medical advisor.
The product is made from early-harvest Greek extra-virgin olive oil and is marketed as containing more than 1,000 mg/kg of polyphenols. Kosterina describes it as a daily “shot” designed to support heart, metabolic, gut, skin and immune health.
Again, there’s a legitimate scientific question underneath the marketing:
Could a much higher concentration of olive-oil phenolics produce additional biological benefits?
Researchers have actually tried to answer that.
And the answer so far is… interesting
A 2023 systematic review and dose-response meta-analysis examined eight randomized clinical trials comparing high- and low-phenol olive oils.
The researchers found that higher-phenol oils reduced oxidized LDL and malondialdehyde, two markers associated with oxidative stress.
They also found a dose-response relationship between phenolic content and oxidized LDL.
That’s genuinely interesting.
It suggests that increasing the phenolic content of olive oil can have measurable biological effects.
But there’s a catch.
A biomarker isn’t a heart attack.
Improving oxidized LDL or another laboratory measurement doesn’t automatically prove that people will live longer or have fewer heart attacks.
That’s a much higher bar.
Earlier research found similar signals
A 2019 systematic review and meta-analysis looked at 26 studies comparing high- and low-polyphenol olive oils.
It found improvements in several cardiovascular risk markers, including oxidized LDL and malondialdehyde, and smaller changes in total and HDL cholesterol.
But the researchers also noted substantial variation between studies and called for longer-term research, including research in non-Mediterranean populations.
So there is a real scientific signal here.
But we’re still mostly looking at risk markers and biological mechanisms, not definitive evidence that an ultra-high-polyphenol oil prevents disease better than ordinary good-quality EVOO.
Then there’s EFSA’s reality check
This is perhaps the most important piece of evidence in the entire story.
In 2025, the European Food Safety Authority evaluated a proposed health claim specifically concerning olive-oil phenolic compounds.
The proposed claim was that these compounds lower LDL cholesterol and systolic blood pressure and therefore reduce coronary heart disease risk.
EFSA examined the human evidence.
Its conclusion?
A cause-and-effect relationship had not been established.
EFSA noted that one intervention study found a reduction in LDL cholesterol, but other studies did not support the finding.
It also found no evidence that the effect persisted with longer-term consumption.
And the studies submitted to support a blood-pressure benefit did not demonstrate an effect.
That’s an important distinction.
It doesn’t mean olive-oil polyphenols don’t do anything.
It means the evidence isn’t strong enough to say:
“More olive-oil polyphenols will lower your LDL and blood pressure.”
But extra-virgin olive oil itself has a pretty good track record
This is where we need to avoid throwing the baby out with the bathwater.
There is substantial evidence supporting extra-virgin olive oil as part of a healthy dietary pattern.
EVOO contains mostly monounsaturated fat, along with numerous minor compounds, including polyphenols.
And recent research continues to investigate associations between EVOO consumption and cardiovascular health.
The important point is that the health benefits associated with EVOO don’t necessarily prove that polyphenols are the sole—or even primary—reason for those benefits.
Olive oil is a whole food.
Its health effects may result from the combination of its fatty acids, phenolic compounds and the dietary pattern in which it is consumed.
So does more polyphenol automatically mean more health?
This is where things get tricky.
We don’t have a proven equation that looks like this:
200 mg/kg = good
500 mg/kg = better
1,000 mg/kg = much better
2,000 mg/kg = spectacular
Human nutrition doesn’t appear to work that neatly.
The research does suggest that increasing phenolic content can influence certain biomarkers.
But we don’t yet have convincing long-term evidence showing that people who consume exceptionally high-polyphenol olive oil experience substantially fewer heart attacks, strokes or other diseases than people consuming good-quality EVOO with lower polyphenol levels.
And we certainly don’t have evidence that an ultra-high-polyphenol oil will make you live longer.
There’s another question I’d like to see answered
If a company charges a premium because its oil contains exceptionally high levels of polyphenols, I’d want to know:
How many milligrams per kilogram?
Not just “high.”
Not just “supercharged.”
A number.
Then:
Who measured it?
And:
Was this particular harvest or batch tested?
That’s important because polyphenol concentration can vary with olive variety, growing conditions, harvest timing, processing and storage.
A product’s marketing description is not the same thing as a laboratory result.
And what about the “30 times” claim?
This is where I’d be particularly cautious.
Gundry’s own materials clearly make the “up to 30×” claim.
But “30 times more than conventional olive oil” doesn’t tell us everything we need to know.
Thirty times what starting concentration?
Measured using which test?
Compared with which oils?
From which harvest?
And most importantly:
Does 30 times more polyphenol produce 30 times more health benefit?
There is no evidence establishing that.
In fact, the available human research doesn’t support such a simple relationship.
The number may be scientifically interesting.
But it isn’t a health outcome.
So what are you actually buying?
If you buy a high-polyphenol olive oil, you’re potentially buying several things:
A particular flavor.
Early-harvest oil.
A particular olive variety.
Organic certification, depending on the product.
A higher concentration of naturally occurring phenolic compounds.
And perhaps the enjoyment of knowing that you’ve chosen a product specifically selected for those characteristics.
Those can all be legitimate reasons to buy it.
But “it contains more polyphenols” doesn’t automatically mean “it will make me healthier.”
That’s the part that hasn’t been established.
The simplest approach may still be the best one
You don’t necessarily need a $30 or $40 bottle of specialty olive oil to eat a healthy diet.
A good extra-virgin olive oil used regularly—particularly when it replaces butter and other fats higher in saturated fat—can fit very comfortably into a Mediterranean-style eating pattern.
If you enjoy a high-polyphenol oil and can afford the premium, there’s nothing inherently wrong with choosing it.
Just understand what the evidence actually says.
The science is promising.
The marketing is more confident.
And those aren’t always the same thing.
The question worth asking
Instead of asking:
“Is this olive oil healthy?”
Ask:
“What additional health benefit has actually been demonstrated from the extra polyphenols?”
That’s a much harder question.
And right now, the honest answer is:
We have evidence of interesting biological effects. We do not yet have strong evidence that exceptionally high-polyphenol olive oil produces substantially better long-term health outcomes than good extra-virgin olive oil.
The takeaway
Extra-virgin olive oil has a legitimate place in a healthy diet.
Olive-oil polyphenols are biologically active compounds, and research suggests that higher-phenol oils can improve some measures of oxidative stress and other biomarkers.
Doctors including Steven Gundry and William Li are taking that science a step further and promoting particularly concentrated high-polyphenol oils. Gundry makes an “up to 30×” hydroxytyrosol claim for his Moroccan oil, while Kosterina says its William Li-developed EVOO shot contains more than 1,000 mg/kg of polyphenols.
But more polyphenols have not been proven to mean proportionally more health.
And EFSA’s 2025 review concluded that a cause-and-effect relationship between olive-oil phenolic compounds and reductions in LDL cholesterol or systolic blood pressure had not been established.
So before paying a premium for a “super olive oil,” remember:
A bigger number on the label isn’t necessarily a bigger health benefit.
Sometimes the most useful thing you can learn about a health product is not whether the claim is true or false.
It’s how much of the claim the evidence can actually support.
Evidence & Sources
Evidence: Moderate. Extra-virgin olive oil has good support as part of a healthy diet, and clinical trials show that higher-phenol olive oils can change certain biological markers such as oxidized LDL. But claims that exceptionally high-polyphenol oils deliver proportionally greater health benefits haven’t been established—the European Food Safety Authority’s 2025 evaluation found the evidence insufficient for LDL-cholesterol and blood-pressure claims, and long-term outcome data are lacking. This article describes product-promoter claims and early findings rather than proven benefits.
- EFSA: 2025 scientific opinion on olive-oil phenolic compounds, LDL cholesterol and blood pressure(opens in a new tab)
- Food Science & Nutrition: Systematic review and dose-response meta-analysis of olive-oil phenols and oxidative-stress biomarkers(opens in a new tab)
- Critical Reviews in Food Science and Nutrition: Systematic review and meta-analysis of high-polyphenol EVOO and cardiovascular risk factors(opens in a new tab)
- PubMed: Randomized trial of high- versus low-polyphenol EVOO and blood pressure(opens in a new tab)
- PubMed: 2026 pilot randomized trial in older adults comparing standard and phenol-enriched EVOO(opens in a new tab)
- Dr. Steven Gundry: Published materials describing the Moroccan olive oil and “up to 30×” claim(opens in a new tab)
- Dr. Steven Gundry: Account describing the Moroccan olive oil and polyphenol testing(opens in a new tab)
- Kosterina: High-phenolic EVOO shot developed with Dr. William Li(opens in a new tab)